The calculation proceeds in two normalization stages. First, subtract the reference-gene Ct from the target-gene Ct within each sample to obtain ΔCt. Next, compare the experimental ΔCt with the calibrator ΔCt to obtain ΔΔCt, then transform that value as 2−ΔΔCt. This sequence separates within-sample normalization from between-sample comparison, making the reported fold change relative rather than absolute.
An appropriate reference gene provides the internal baseline for each sample. Its Ct is used to normalize target-gene measurements before samples are compared. If that reference does not remain stable across experimental conditions, the calculated change can reflect variation in the baseline rather than a genuine difference in target expression. Reference selection therefore directly affects the interpretation of the result.
Comparable amplification efficiencies support the mathematical interpretation of 2−ΔΔCt as a fold change. The target and reference measurements must therefore behave sufficiently similarly during amplification for their Ct differences to provide a meaningful comparison. When this assumption is not appropriate, the calculated value may not accurately represent the relative expression difference between the experimental and calibrator samples.
The calibrator establishes the comparison point for normalized expression. After each sample’s target measurement is adjusted using its reference-gene Ct, the experimental sample is evaluated against the calibrator’s normalized value. The resulting fold change describes expression relative to that selected baseline, so changing the calibrator changes the frame of interpretation without converting the analysis into absolute quantification.
The analysis requires Ct measurements for both the target gene and a stable reference gene in the samples being compared, together with a designated calibrator sample. These values are first combined within each sample to generate normalized target measurements, then compared across the experimental and calibrator groups. The workflow produces a relative expression result rather than an absolute transcript amount.
A 2−ΔΔCt result expresses the target gene’s relative change compared with the chosen calibrator after reference-gene normalization. It does not provide an absolute copy number or an absolute concentration of transcript. Interpretation should therefore remain tied to the reference and calibrator used, as well as to the assumption of comparable amplification efficiencies.
In genetics, the approach can compare transcriptional responses between experimental conditions, examine allele- or condition-associated expression differences, and evaluate molecular effects of mutations or treatments. Its relative design is useful when the research question concerns expression change between defined samples rather than absolute quantification. These comparisons can connect genetic differences or interventions with altered target-gene expression.